Infliximab and biosimilar is a tumor necrosis factor blocker intended for patients with rheumatoid arthritis, in combination with methotrexate, as well as for patients with Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Infliximab and biosimilar industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Infliximab
infliximab-dyyb
infliximab-abda
Market Segment by Product Application
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Plaque Psoriasis
Finally, the report provides detailed profile and data information analysis of leading company.
Janssen Biotech
Merck and Co.
Pfizer
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Infliximab and biosimilar consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Infliximab and biosimilar market by identifying its various subsegments.
3.Focuses on the key global Infliximab and biosimilar manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Infliximab and biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Infliximab and biosimilar submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Infliximab and biosimilar Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Infliximab and biosimilar Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Infliximab and biosimilar Segment by Type
2.1.1 Infliximab
2.1.2 infliximab-dyyb
2.1.3 infliximab-abda
2.2 Market Analysis by Application
2.2.1 Crohn's Disease
2.2.2 Pediatric Crohn's Disease
2.2.3 Ulcerative Colitis
2.2.4 Rheumatoid Arthritis
2.2.5 Ankylosing Spondylitis
2.2.6 Psoriatic Arthritis
2.2.7 Plaque Psoriasis
2.3 Global Infliximab and biosimilar Market Comparison by Regions (2017-2027)
2.3.1 Global Infliximab and biosimilar Market Size (2017-2027)
2.3.2 North America Infliximab and biosimilar Status and Prospect (2017-2027)
2.3.3 Europe Infliximab and biosimilar Status and Prospect (2017-2027)
2.3.4 China Infliximab and biosimilar Status and Prospect (2017-2027)
2.3.5 Japan Infliximab and biosimilar Status and Prospect (2017-2027)
2.3.6 Southeast Asia Infliximab and biosimilar Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Infliximab and biosimilar Industry Impact
2.5.1 Infliximab and biosimilar Business Impact Assessment - Covid-19
2.5.2 Market Trends and Infliximab and biosimilar Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Infliximab and biosimilar Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Infliximab and biosimilar Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Infliximab and biosimilar Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Infliximab and biosimilar Manufacturer Market Share
3.5 Top 10 Infliximab and biosimilar Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Infliximab and biosimilar Market
3.7 Key Manufacturers Infliximab and biosimilar Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Infliximab and biosimilar Industry Key Manufacturers
4.1 Janssen Biotech
4.1.1 Compan Detail
4.1.2 Janssen Biotech Infliximab and biosimilar Product Introduction, Application and Specification
4.1.3 Janssen Biotech 139 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Janssen Biotech News
4.2 Merck and Co.
4.2.1 Compan Detail
4.2.2 Merck and Co. Infliximab and biosimilar Product Introduction, Application and Specification
4.2.3 Merck and Co. Infliximab and biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Janssen Biotech News
4.3 Pfizer
4.3.1 Compan Detail
4.3.2 Pfizer Infliximab and biosimilar Product Introduction, Application and Specification
4.3.3 Pfizer Infliximab and biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Pfizer News
5 Global Infliximab and biosimilar Market Segment by Big Type
5.1 Global Infliximab and biosimilar Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Infliximab and biosimilar Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Infliximab and biosimilar Revenue and Market Share by Big Type (2017-2022)
5.2 Infliximab Sales Growth Rate and Price
5.2.1 Global Infliximab Sales Growth Rate (2017-2022)
5.2.2 Global Infliximab Price (2017-2022)
5.3 infliximab-dyyb Sales Growth Rate and Price
5.3.1 Global infliximab-dyyb Sales Growth Rate (2017-2022)
5.3.2 Global infliximab-dyyb Price (2017-2022)
5.4 infliximab-abda Sales Growth Rate and Price
5.4.1 Global infliximab-abda Sales Growth Rate (2017-2022)
5.4.2 Global infliximab-abda Price (2017-2022)
6 Global Infliximab and biosimilar Market Segment by Big Application
6.1 Global Infliximab and biosimilar Sales Market Share by Big Application (2017-2022)
6.2 Crohn's Disease Sales Growth Rate (2017-2022)
6.3 Pediatric Crohn's Disease Sales Growth Rate (2017-2022)
6.4 Ulcerative Colitis Sales Growth Rate (2017-2022)
6.5 Rheumatoid Arthritis Sales Growth Rate (2017-2022)
6.6 Ankylosing Spondylitis Sales Growth Rate (2017-2022)
6.7 Psoriatic Arthritis Sales Growth Rate (2017-2022)
6.8 Plaque Psoriasis Sales Growth Rate (2017-2022)
7 Global Infliximab and biosimilar Forecast
7.1 Global Infliximab and biosimilar Revenue, Sales and Growth Rate (2022-2027)
7.2 Infliximab and biosimilar Market Forecast by Regions (2022-2027)
7.2.1 North America Infliximab and biosimilar Market Forecast (2022-2027)
7.2.2 Europe Infliximab and biosimilar Market Forecast (2022-2027)
7.2.3 China Infliximab and biosimilar Market Forecast (2022-2027)
7.2.4 Japan Infliximab and biosimilar Market Forecast (2022-2027)
7.2.5 Southeast Asia Infliximab and biosimilar Market Forecast (2022-2027)
7.2.6 Other Regions Infliximab and biosimilar Market Forecast (2022-2027)
7.3 Infliximab and biosimilar Market Forecast by Type (2022-2027)
7.3.1 Global Infliximab and biosimilar Sales Forecast by Type (2022-2027)
7.3.2 Global Infliximab and biosimilar Market Share Forecast by Type (2022-2027)
7.4 Infliximab and biosimilar Market Forecast by Application (2022-2027)
7.4.1 Global Infliximab and biosimilar Sales Forecast by Application (2022-2027)
7.4.2 Global Infliximab and biosimilar Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Infliximab and biosimilar Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Infliximab and biosimilar Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Infliximab and biosimilar
Figure Market Concentration Ratio and Market Maturity Analysis of Infliximab and biosimilar
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Infliximab and biosimilar Market Size by Big Type
Figure Global Market Share of Infliximab and biosimilar by Big Type in 2021
Figure Infliximab Picture (2017-2022)
Figure infliximab-dyyb Picture (2017-2022)
Global Infliximab and biosimilar Market Size by Big Application
Table Global Infliximab and biosimilar Market Size by Application
Figure Global Infliximab and biosimilar Market Share by Big Application in 2021
Figure Crohn's Disease Picture
Figure Pediatric Crohn's Disease Picture
Figure Ulcerative Colitis Picture
Figure Rheumatoid Arthritis Picture
Figure Ankylosing Spondylitis Picture
Figure Psoriatic Arthritis Picture
Figure Plaque Psoriasis Picture
Table Global Infliximab and biosimilar Comparison by Regions (M USD) (2017-2027)
Figure Global Infliximab and biosimilar Market Size (Million US$) (2017-2027)
Figure North America Infliximab and biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Infliximab and biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure China Infliximab and biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Infliximab and biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Infliximab and biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Infliximab and biosimilar Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Infliximab and biosimilar Sales by Manufacturer (2017-2022)
Figure Global Infliximab and biosimilar Sales Market Share by Manufacturer in 2021
Table Global Infliximab and biosimilar Revenue by Manufacturer (2017-2022)
Figure Global Infliximab and biosimilar Revenue Market Share by Manufacturer in 2021
Table Global Infliximab and biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Infliximab and biosimilar Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Infliximab and biosimilar Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Infliximab and biosimilar Market
Table Key Manufacturers Infliximab and biosimilar Product Type
Table Mergers & Acquisitions Planning
Table Janssen Biotech Company Profile
Table Infliximab and biosimilar Product Introduction, Application and Specification of Janssen Biotech
Table Infliximab and biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Merck and Co. Company Profile
Table Infliximab and biosimilar Product Introduction, Application and Specification of Merck and Co.
Table Infliximab and biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck and Co. Recent Development
Table Pfizer Company Profile
Table Infliximab and biosimilar Product Introduction, Application and Specification of Pfizer
Table Infliximab and biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Figure Global Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure Global Infliximab and biosimilar Revenue and Growth Rate (2017-2022)
Table Global Infliximab and biosimilar Sales by Regions (2017-2022)
Figure Global Infliximab and biosimilar Sales Market Share by Regions in 2021
Table Global Infliximab and biosimilar Revenue by Regions (2017-2022)
Figure Global Infliximab and biosimilar Revenue Market Share by Regions in 2021
Figure North America Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure Europe Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure China Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure Japan Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure Southeast Asia Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Figure Other Regions Infliximab and biosimilar Sales and Growth Rate (2017-2022)
Table Global Infliximab and biosimilar Sales by Big Type (2017-2022)
Table Global Infliximab and biosimilar Sales Market Share by Big Type (2017-2022)
Figure Global Infliximab and biosimilar Sales Market Share by Big Type in 2019
Table Global Infliximab and biosimilar Revenue by Big Type (2017-2022)
Table Global Infliximab and biosimilar Revenue Market Share by Big Type (2017-2022)
Table Global Infliximab and biosimilar Revenue Market Share by Big Type in 2019
Figure Global Infliximab Sales Growth Rate (2017-2022)
Figure Global Infliximab Price (2017-2022)
Figure Global infliximab-dyyb Sales Growth Rate (2017-2022)
Figure Global infliximab-dyyb Price (2017-2022)
Figure Global infliximab-abda Sales Growth Rate (2017-2022)
Table Global Infliximab and biosimilar Sales by Big Application (2017-2022)
Table Global Infliximab and biosimilar Sales Market Share by Big Application (2017-2022)
Figure Global Infliximab and biosimilar Sales Market Share by Big Application in 2019
Figure Global Crohn's Disease Sales Growth Rate (2017-2022)
Figure Global Pediatric Crohn's Disease Sales Growth Rate (2017-2022)
Figure Global Ulcerative Colitis Sales Growth Rate (2017-2022)
Figure Global Rheumatoid Arthritis Sales Growth Rate (2017-2022)
Figure Global Ankylosing Spondylitis Sales Growth Rate (2017-2022)
Figure Global Psoriatic Arthritis Sales Growth Rate (2017-2022)
Figure Global Plaque Psoriasis Sales Growth Rate (2017-2022)
Figure Global Infliximab and biosimilar Sales and Growth Rate (2022-2027)
Figure Global Infliximab and biosimilar Revenue and Growth Rate (2022-2027)
Table Global Infliximab and biosimilar Sales Forecast by Regions (2022-2027)
Table Global Infliximab and biosimilar Market Share Forecast by Regions (2022-2027)
Figure North America Sales Infliximab and biosimilar Market Forecast (2022-2027)
Figure Europe Sales Infliximab and biosimilar Market Forecast (2022-2027)
Figure China Sales Infliximab and biosimilar Market Forecast (2022-2027)
Figure Japan Sales Infliximab and biosimilar Market Forecast (2022-2027)
Figure Southeast Asia Sales Infliximab and biosimilar Market Forecast (2022-2027)
Figure Other Regions Sales Infliximab and biosimilar Market Forecast (2022-2027)
Table Global Infliximab and biosimilar Sales Forecast by Type (2022-2027)
Table Global Infliximab and biosimilar Market Share Forecast by Type (2022-2027)
Table Global Infliximab and biosimilar Sales Forecast by Application (2022-2027)
Table Global Infliximab and biosimilar Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Infliximab and biosimilar
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Infliximab and biosimilar Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Infliximab and biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Infliximab and biosimilar Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Infliximab and biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Infliximab and biosimilar Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Infliximab and biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Infliximab and biosimilar Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Infliximab and biosimilar Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Janssen Biotech
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)